<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02049983</url>
  </required_header>
  <id_info>
    <org_study_id>LEV-TP-0010</org_study_id>
    <secondary_id>Grant 13IEAT-20911</secondary_id>
    <nct_id>NCT02049983</nct_id>
  </id_info>
  <brief_title>Levita Magnetic Grasper Device Safety and Performance Study</brief_title>
  <official_title>Levita Magnetic Grasper Device Safety and Performance Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Levita Magnetics</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Levita Magnetics</source>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine the Levita Magnetic Grasper Device Safety and&#xD;
      Performance in Laparoscopy.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2014</start_date>
  <completion_date type="Actual">March 2015</completion_date>
  <primary_completion_date type="Actual">March 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Safety</measure>
    <time_frame>One month</time_frame>
    <description>Absence of any damage or side effect to the patient directly produced by the device during the surgery</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Feasibility</measure>
    <time_frame>Intra-operative</time_frame>
    <description>Ability to adequately mobilize the organ during the surgery</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">50</enrollment>
  <condition>Benign Gallbladder Disease</condition>
  <arm_group>
    <arm_group_label>Use of Levita Magnetics Grasper</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Use of Levita Magnetics Grasper</intervention_name>
    <arm_group_label>Use of Levita Magnetics Grasper</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patient is between 18 and 60 years of age&#xD;
&#xD;
               -  Undergoing elective cholecystectomy due to:&#xD;
&#xD;
               -  Cholelithiasis (Gallbladder stones &lt; 2.5cm in longer measurement (length or&#xD;
                  width))&#xD;
&#xD;
               -  Gallbladder polyps as assessed by ultrasound&#xD;
&#xD;
               -  Absence of non-correctable coagulopathy (INR &lt; 1.4 or, platelet count of &lt;&#xD;
                  50,000/mcl)&#xD;
&#xD;
               -  Patient has a body mass index (BMI) â‰¤ 35 kg/m2 and over 20&#xD;
&#xD;
               -  Patient, or authorized representative, signs a written Informed Consent form to&#xD;
                  participate in the study, prior to any study mandated determinations or procedure&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Emergency presentation with acute gallbladder disease&#xD;
&#xD;
               -  Pancreatitis&#xD;
&#xD;
               -  Jaundice&#xD;
&#xD;
               -  Scleroatrophic gallbladder as shown by ultrasound&#xD;
&#xD;
               -  Biliary tract stones diagnosed before or during surgery&#xD;
&#xD;
               -  Acute cholecystitis&#xD;
&#xD;
               -  Gallbladder Empyema&#xD;
&#xD;
               -  Ongoing peritoneal dialysis&#xD;
&#xD;
               -  Previous abdominal surgery or laparotomy (presence of any previous upper&#xD;
                  umbilical incision)&#xD;
&#xD;
               -  Presence of umbilical hernia or previous umbilical hernia&#xD;
&#xD;
               -  American Society of Anesthesiologists (ASA) score of III or IV&#xD;
&#xD;
               -  Patient is undergoing treatment for chronic pain of any origin&#xD;
&#xD;
               -  Significant comorbidities: cardiovascular, neuromuscular, chronic obstructive&#xD;
                  pulmonary disease, and urological disease (renal failure)&#xD;
&#xD;
               -  Patients with signs of gallbladder perforation diagnosed by ultrasound&#xD;
&#xD;
               -  Suspicion of biliary cancer&#xD;
&#xD;
               -  Patients with severe peritonitis&#xD;
&#xD;
               -  Contraindications to pneumoperitoneum&#xD;
&#xD;
               -  Known allergy to paracetamol or NSAIDs&#xD;
&#xD;
               -  Patients with metallic implants (such as pacemakers, prosthesis, etc)&#xD;
&#xD;
               -  Previously diagnosed or suspected of having a history of choledocholithiasis&#xD;
                  based on any alterations in plasma hepatic enzymes&#xD;
&#xD;
               -  Has a biliary tract &gt; 7mm in size as determined by ultrasound&#xD;
&#xD;
               -  Has a gallbladder wall thickness that is &gt; 5mm&#xD;
&#xD;
               -  Diabetic Blood coagulation issues&#xD;
&#xD;
               -  Has signs of hepatic endocrinology (i.e: cirrhosis, liver failure, increase in&#xD;
                  liver enzymes, etc.)&#xD;
&#xD;
               -  History of endoscopic papillotomy (i.e: Preoperative indication of endoscopic&#xD;
                  retrograde cholangiopancreatography (ERCP)&#xD;
&#xD;
               -  Patient is pregnant or wishes to become pregnant during the length of study&#xD;
                  participation or lactation&#xD;
&#xD;
               -  Patient is not likely to comply with the follow-up evaluation schedule&#xD;
&#xD;
               -  Patient is participating in a clinical trial of another investigational drug or&#xD;
                  device&#xD;
&#xD;
               -  Patient is mentally incompetent or a prisoner&#xD;
&#xD;
               -  Known or suspected drug or alcohol abuse&#xD;
&#xD;
               -  Patient has systemic infection or evidence of any surgical site infection&#xD;
                  (superficial or organ space)&#xD;
&#xD;
               -  Patient has compromised immune system or autoimmune disease (WBC &lt; 4000 or &gt;&#xD;
                  20,000), including prior or pending treatment for HIV or Hep. C&#xD;
&#xD;
               -  Patient intra-operatively needs an additional surgery while undergoing elective&#xD;
                  cholecystectomy&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Hospital Luis Tisne</name>
      <address>
        <city>Santiago</city>
        <country>Chile</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Padre Hurtado</name>
      <address>
        <city>Santiago</city>
        <country>Chile</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Salvador</name>
      <address>
        <city>Santiago</city>
        <country>Chile</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Chile</country>
  </location_countries>
  <verification_date>March 2015</verification_date>
  <study_first_submitted>January 28, 2014</study_first_submitted>
  <study_first_submitted_qc>January 29, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 30, 2014</study_first_posted>
  <last_update_submitted>March 10, 2015</last_update_submitted>
  <last_update_submitted_qc>March 10, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 11, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Gallbladder Diseases</mesh_term>
  </condition_browse>
  <pending_results>
    <submitted>January 18, 2018</submitted>
    <returned>September 20, 2018</returned>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

